Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients

NCT06991712 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
138
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Christopher Kai Shun Leung